Back
Terns Pharmaceuticals Vs. Biomarin Pharmaceutical Industry Stock Comparison
Sell
37
TERN
Terns Pharmaceuticals
Last Price:
$5.81
Seasonality Move:
-2.1%
Buy
62
BMRN
Biomarin Pharmaceutical
Last Price:
$66.90
Seasonality Move:
5.39%
Sell
37
Terns Pharmaceuticals (TERN)
is a Sell
Is Terns Pharmaceuticals a Buy, Sell or Hold?
-
The current Terns Pharmaceuticals [TERN] share price is $5.80. The Score for TERN is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
TERN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
-
The current Biomarin Pharmaceutical [BMRN] share price is $66.63. The Score for BMRN is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TERN Stock Price Chart
What is Terns Pharmaceuticals's stock price today?
-
The Terns Pharmaceuticals share price today is $5.80Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TERN is experiencing slight selling pressure.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $66.63The current trend is relatively stagnant and BMRN is experiencing slight buying pressure.
TERN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.18 | Sell |
Relative Strength Index (14 RSI): | 40.77 | Sell |
Chaikin Money Flow: | -36203 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.82 - 6.7) | Sell |
Bollinger Bands (100): | (6.22 - 8.6) | Sell |
BMRN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 52.97 | Buy |
Chaikin Money Flow: | 220105 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (64.01 - 66.69) | Buy |
Bollinger Bands (100): | (63.82 - 83.66) | Sell |
TERN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.24 | Sell |
20-day SMA: | 6.39 | Sell |
50-day SMA: | 6.63 | Sell |
200-day SMA: | 7.02 | Sell |
8-day EMA: | 6.11 | Sell |
20-day EMA: | 6.32 | Sell |
50-day EMA: | 6.7 | Sell |
200-day EMA: | 7.07 | Sell |
BMRN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 65.87 | Buy |
20-day SMA: | 65.82 | Buy |
50-day SMA: | 66.54 | Buy |
200-day SMA: | 78.72 | Sell |
8-day EMA: | 65.99 | Buy |
20-day EMA: | 65.87 | Buy |
50-day EMA: | 67.53 | Sell |
200-day EMA: | 76.81 | Sell |
Terns Pharmaceuticals Earnings Growth & TERN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and a decrease next year of $0.12 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.90 per share.
Terns Pharmaceuticals Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Biomarin Pharmaceutical Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |